382 related articles for article (PubMed ID: 22484185)
21. A Vismodegib Experience in Elderly Patients with Basal Cell Carcinoma: Case Reports and Review of the Literature.
Passarelli A; Galdo G; Aieta M; Fabrizio T; Villonio A; Conca R
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202689
[TBL] [Abstract][Full Text] [Related]
22. Hedgehog inhibitors in the treatment of advanced basal cell carcinoma: risks and benefits.
Villani A; Cinelli E; Fabbrocini G; Lallas A; Scalvenzi M
Expert Opin Drug Saf; 2020 Dec; 19(12):1585-1594. PubMed ID: 33054455
[TBL] [Abstract][Full Text] [Related]
23. Synergistic cross-talk of hedgehog and interleukin-6 signaling drives growth of basal cell carcinoma.
Sternberg C; Gruber W; Eberl M; Tesanovic S; Stadler M; Elmer DP; Schlederer M; Grund S; Roos S; Wolff F; Kaur S; Mangelberger D; Lehrach H; Hache H; Wierling C; Laimer J; Lackner P; Wiederstein M; Kasper M; Risch A; Petzelbauer P; Moriggl R; Kenner L; Aberger F
Int J Cancer; 2018 Dec; 143(11):2943-2954. PubMed ID: 29987839
[TBL] [Abstract][Full Text] [Related]
24. Systemic therapy for inoperable and metastatic basal cell cancer.
Fecher LA
Curr Treat Options Oncol; 2013 Jun; 14(2):237-48. PubMed ID: 23558911
[TBL] [Abstract][Full Text] [Related]
25. Targeting Hedgehog signaling and understanding refractory response to treatment with Hedgehog pathway inhibitors.
Queiroz KC; Spek CA; Peppelenbosch MP
Drug Resist Updat; 2012 Aug; 15(4):211-22. PubMed ID: 22910179
[TBL] [Abstract][Full Text] [Related]
26. Chemopreventive opportunities to control basal cell carcinoma: Current perspectives.
Tilley C; Deep G; Agarwal R
Mol Carcinog; 2015 Sep; 54(9):688-97. PubMed ID: 26053157
[TBL] [Abstract][Full Text] [Related]
27. A cell identity switch allows residual BCC to survive Hedgehog pathway inhibition.
Biehs B; Dijkgraaf GJP; Piskol R; Alicke B; Boumahdi S; Peale F; Gould SE; de Sauvage FJ
Nature; 2018 Oct; 562(7727):429-433. PubMed ID: 30297801
[TBL] [Abstract][Full Text] [Related]
28. The Hedgehog pathway and its inhibitors: Emerging therapeutic approaches for basal cell carcinoma.
Jain R; Dubey SK; Singhvi G
Drug Discov Today; 2022 Apr; 27(4):1176-1183. PubMed ID: 34896624
[TBL] [Abstract][Full Text] [Related]
29. Locally advanced and metastatic basal cell carcinoma: molecular pathways, treatment options and new targeted therapies.
Ruiz Salas V; Alegre M; Garcés JR; Puig L
Expert Rev Anticancer Ther; 2014 Jun; 14(6):741-9. PubMed ID: 24611655
[TBL] [Abstract][Full Text] [Related]
30. Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway Interactions.
Urman NM; Mirza A; Atwood SX; Whitson RJ; Sarin KY; Tang JY; Oro AE
PLoS One; 2016; 11(12):e0168031. PubMed ID: 28030567
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of Hedgehog pathway inhibitors in Basal cell carcinoma.
Basset-Seguin N; Sharpe HJ; de Sauvage FJ
Mol Cancer Ther; 2015 Mar; 14(3):633-41. PubMed ID: 25585509
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of vismodegib : a new therapeutic agent in the treatment of basal cell carcinoma.
Lyons TG; O'Kane GM; Kelly CM
Expert Opin Drug Saf; 2014 Aug; 13(8):1125-32. PubMed ID: 25033383
[TBL] [Abstract][Full Text] [Related]
33. Review of the hair follicle origin hypothesis for basal cell carcinoma.
Donovan J
Dermatol Surg; 2009 Sep; 35(9):1311-23. PubMed ID: 19496793
[TBL] [Abstract][Full Text] [Related]
34. Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions.
Williams JA; Guicherit OM; Zaharian BI; Xu Y; Chai L; Wichterle H; Kon C; Gatchalian C; Porter JA; Rubin LL; Wang FY
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4616-21. PubMed ID: 12679522
[TBL] [Abstract][Full Text] [Related]
35. Interaction of hedgehog and vitamin D signaling pathways in basal cell carcinomas.
Albert B; Hahn H
Adv Exp Med Biol; 2014; 810():329-41. PubMed ID: 25207374
[TBL] [Abstract][Full Text] [Related]
36. Silibinin Treatment Inhibits the Growth of Hedgehog Inhibitor-Resistant Basal Cell Carcinoma Cells via Targeting EGFR-MAPK-Akt and Hedgehog Signaling.
Dheeraj A; Rigby CM; O'Bryant CL; Agarwal C; Singh RP; Deep G; Agarwal R
Photochem Photobiol; 2017 Jul; 93(4):999-1007. PubMed ID: 28120452
[TBL] [Abstract][Full Text] [Related]
37. INTU is essential for oncogenic Hh signaling through regulating primary cilia formation in basal cell carcinoma.
Yang N; Leung EL; Liu C; Li L; Eguether T; Jun Yao XJ; Jones EC; Norris DA; Liu A; Clark RA; Roop DR; Pazour GJ; Shroyer KR; Chen J
Oncogene; 2017 Aug; 36(35):4997-5005. PubMed ID: 28459465
[TBL] [Abstract][Full Text] [Related]
38. Correlations between the Sonic Hedgehog pathway and basal cell carcinoma.
Lupi O
Int J Dermatol; 2007 Nov; 46(11):1113-7. PubMed ID: 17988327
[TBL] [Abstract][Full Text] [Related]
39. Understanding the Molecular Genetics of Basal Cell Carcinoma.
Pellegrini C; Maturo MG; Di Nardo L; Ciciarelli V; Gutiérrez García-Rodrigo C; Fargnoli MC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165358
[TBL] [Abstract][Full Text] [Related]
40. Posaconazole, a Second-Generation Triazole Antifungal Drug, Inhibits the Hedgehog Signaling Pathway and Progression of Basal Cell Carcinoma.
Chen B; Trang V; Lee A; Williams NS; Wilson AN; Epstein EH; Tang JY; Kim J
Mol Cancer Ther; 2016 May; 15(5):866-76. PubMed ID: 26823493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
